🚀 VC round data is live in beta, check it out!

Innospec Valuation Multiples

Discover revenue and EBITDA valuation multiples for Innospec and similar public comparables like Saudi Chemical, Advanced Petrochemical, Solvac, FMC and more.

Innospec Overview

About Innospec

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.


Founded

1998

HQ

United States

Employees

2.5K

Sectors

Financials (LTM)

Revenue: $2B
EBITDA: $200M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Innospec Financials

Innospec reported last 12-month revenue of $2B and EBITDA of $200M.

In the same LTM period, Innospec generated $498M in gross profit, $200M in EBITDA, and $118M in net income.

Revenue (LTM)


Innospec P&L

In the most recent fiscal year, Innospec reported revenue of $2B and EBITDA of $203M.

Innospec is profitable as of last fiscal year, with gross margin of 28%, EBITDA margin of 11%, and net margin of 7%.

See analyst estimates for Innospec
LTMLast FY202320242025202620272028
Revenue$2B$2B$2B$2B$2B
Gross Profit$498M$492M$591M$543M$492M
Gross Margin28%28%30%29%28%
EBITDA$200M$203M$201M$225M$200M
EBITDA Margin11%11%10%12%11%
EBIT Margin8%9%8%10%9%
Net Profit$118M$117M$139M$36M$117M
Net Margin7%7%7%2%7%

Financial data powered by Morningstar, Inc.

Innospec Stock Performance

Innospec has current market cap of $2B, and enterprise value of $2B.

Market Cap Evolution


Innospec's stock price is $76.26.

Innospec share price decreased by 10.4% in the last year.

Innospec has an EPS (earnings per share) of $4.68.

See more trading valuation data for Innospec
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B0.8%—-0.4%-10.4%$4.68

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Innospec Valuation Multiples

Innospec trades at 0.9x EV/Revenue multiple, and 8.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Innospec

EV / Revenue (LTM)


Innospec Financial Valuation Multiples

As of May 1, 2026, Innospec has market cap of $2B and EV of $2B.

Innospec has a P/E ratio of 16.1x.

LTMLast FY202320242025202620272028
EV/Revenue0.9x0.9x0.9x0.9x0.9x
EV/EBITDA8.3x8.2x8.3x7.4x8.3x
EV/EBIT10.9x10.6x10.3x9.2x10.6x
EV/Gross Profit3.3x3.4x2.8x3.1x3.4x
P/E16.1x16.3x13.6x53.3x16.3x
EV/FCF26.4x26.4x12.7x13.6x26.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Innospec Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Innospec Margins & Growth Rates

Innospec grew revenue by 5% but EBITDA decreased by 5% in the last fiscal year.

In the most recent fiscal year, Innospec reported gross margin of 28%, EBITDA margin of 11%, and net margin of 7%.

See estimated margins and future growth rates for Innospec

Innospec Margins

Last FY202420252026202720282029
Gross Margin28%29%28%27%
EBITDA Margin11%12%11%10%
EBIT Margin9%10%9%9%
Net Margin7%2%7%6%
FCF Margin4%7%4%3%

Innospec Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth5%(5%)(4%)5%
Gross Profit Growth3%(8%)(9%)3%
EBITDA Growth(5%)12%(11%)(4%)
EBIT Growth2%12%(14%)2%
Net Profit Growth2%(74%)228%2%
FCF Growth0%(6%)(49%)0%

Data powered by FactSet, Inc. and Morningstar, Inc.

Innospec Operational KPIs

Innospec's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.1M for the same period.

Innospec's Rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Innospec's Rule of X is 23% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Innospec
LTMLast FY202320242025202620272028
Rule of 4017%15%———
Bessemer Rule of X26%23%———
Revenue per Employee—$0.7M———
Opex per Employee—$0.1M———
R&D Expenses to Revenue3%3%2%3%3%
Opex to Revenue—19%22%20%19%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Innospec Competitors

Innospec competitors include Saudi Chemical, Advanced Petrochemical, Solvac, FMC, Castrol India, National Industralization, Robertet, Elkem, CAC Nantong Chemical Co and Lanxess.

Most Innospec public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Saudi Chemical1.2x—14.7x—
Advanced Petrochemical4.7x4.1x19.7x16.9x
Solvac——13.6x—
FMC1.7x1.6x(4.1x)7.7x
Castrol India2.9x2.8x12.2x12.3x
National Industralization4.4x4.1x(17.2x)(6.1x)
Robertet2.0x2.0x9.7x9.9x
Elkem1.6x0.9x6.9x9.5x

This data is available for Pro users. Sign up to see all Innospec competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Innospec

When was Innospec founded?Innospec was founded in 1998.
Where is Innospec headquartered?Innospec is headquartered in United States.
How many employees does Innospec have?As of today, Innospec has over 2K employees.
Who is the CEO of Innospec?Innospec's CEO is Patrick S. Williams.
Is Innospec publicly listed?Yes, Innospec is a public company listed on Nasdaq.
What is the stock symbol of Innospec?Innospec trades under IOSP ticker.
When did Innospec go public?Innospec went public in 1998.
Who are competitors of Innospec?Innospec main competitors include Saudi Chemical, Advanced Petrochemical, Solvac, FMC, Castrol India, National Industralization, Robertet, Elkem, CAC Nantong Chemical Co, Lanxess.
What is the current market cap of Innospec?Innospec's current market cap is $2B.
What is the current revenue of Innospec?Innospec's last 12 months revenue is $2B.
What is the current revenue growth of Innospec?Innospec revenue growth (NTM/LTM) is 6%.
What is the current EV/Revenue multiple of Innospec?Current revenue multiple of Innospec is 0.9x.
Is Innospec profitable?Yes, Innospec is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Innospec?Innospec's last 12 months EBITDA is $200M.
What is Innospec's EBITDA margin?Innospec's last 12 months EBITDA margin is 11%.
What is the current EV/EBITDA multiple of Innospec?Current EBITDA multiple of Innospec is 8.3x.
What is the current FCF of Innospec?Innospec's last 12 months FCF is $63M.
What is Innospec's FCF margin?Innospec's last 12 months FCF margin is 3%.
What is the current EV/FCF multiple of Innospec?Current FCF multiple of Innospec is 26.4x.
How many companies Innospec has acquired to date?Innospec hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Innospec has invested to date?Innospec hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Innospec

Lists including Innospec

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial